Subdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Dominguez, Mariana R ^a   Silveira, Eduardo L V ^a,e   de Vasconcelos, José Ronnie C ^a   de Alencar, Bruna C G ^a,f   Machado, Alexandre V ^b   Bruna Romero, Oscar ^c   Gazzinelli, Ricardo T ^c,d   Rodrigues, Mauricio M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e EMORY UNIVERSITY   (United States)

^f PSL RESEARCH UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; EPITOPE; PLASMID DNA; RECOMBINANT VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC IMMUNIZATION; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; MOUSE; NONHUMAN; PARASITEMIA; RAT; TRYPANOSOMA CRUZI; ANIMAL; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

ADENOVIRIDAE; MUS; PROTOZOA; TRYPANOSOMA CRUZI;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; MICE; PEPTIDES; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960333300     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022011     Document Type: Article

References (57)

1. Tarleton RL, (2007) Immune system recognition of Trypanosoma cruzi. Curr Opin Immunol 19: 430-4.
2. Miyahira Y, (2008) Trypanosoma cruzi infection from the view of CD8+ T cell immunity-an infection model for developing T cell vaccine. Parasitol Int 57: 38-48.
3. Padilla AM, Bustamante JM, Tarleton RL, (2009) CD8+ T cells in Trypanosoma cruzi infection. Curr Opin Immunol 21: 385-90.
4. Boscardin SB, Torrecilhas AC, Manarin R, Revelli S, Rey EG, et al. (2010) Chagas' disease: an update on immune mechanisms and therapeutic strategies. J Cell Mol Med 14: 1373-84.
5. Junqueira C, Caetano B, Bartholomeu DC, Melo MB, Ropert C, et al. (2010) The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease. Expert Rev Mol Med 12: e29.
6. Kierszenbaum F, (2005) Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol 21: 513-6.
7. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV, (2008) Pathogenesis of chronic Chagas heart disease. Circulation 115: 1109-23.
8. Bonney KM, Engman DM, (2008) Chagas heart disease pathogenesis: one mechanism or many? Curr Mol Med 8: 510-8.
9. Gutierrez FR, Guedes PM, Gazzinelli RT, Silva JS, (2009) The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol 31: 673-85.
10. Scharfstein J, Gomes Jde A, Correa-Oliveira R, (2009) Mem Inst Oswaldo Cruz. Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research 104 (Suppl 1): 187-98.
11. Lannes-Vieira J, Silverio JC, Pereira IR, Vinagre NF, Carvalho CM, et al. (2009) Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors-how to make a dream come true. Mem Inst Oswaldo Cruz 104 (Suppl 1): 226-35.
12. Tzelepis F, de Alencar BC, Penido ML, Gazzinelli RT, Persechini PM, et al. (2006) Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice. Infect Immun 74: 2477-81.
13. Martin DL, Weatherly DB, Laucella SA, Cabinian MA, Crim MT, et al. (2006) CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2 (8): e77.
14. Tzelepis F, Persechini PM, Rodrigues MM, (2007) Modulation of CD4+ T cell-dependent specific cytotoxic CD8+ T cells differentiation and proliferation by the timing of increase in the pathogen load. PLoS One 2 (4): e393.
15. Tzelepis F, de Alencar BC, Penido ML, Claser C, Machado AV, et al. (2008) Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance. J Immunol 180: 1737-48.
16. Bixby LM, Tarleton RL, (2008) Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection. J Immunol 181: 2644-50.
17. Rosenberg CS, Martin DL, Tarleton RL, (2010) CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J Immunol 185: 560-8.
18. Freire-de-Lima L, Alisson-Silva F, Carvalho ST, Takiya CM, Rodrigues MM, et al. (2010) Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses. J Biol Chem 285: 13388-96.
19. Oliveira AC, de Alencar BC, Tzelepis F, Klezewsky W, da Silva RN, et al. (2010) Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice 29; 6 (4): e1000870.
20. Rodrigues MM, de Alencar BC, Claser C, Tzelepis F, (2009) Immunodominance: a new hypothesis to explain parasite escape and host/parasite equilibrium leading to the chronic phase of Chagas' disease? Braz J Med Biol Res 42: 220-3.
21. Chen W, Antón LC, Bennink JR, Yewdell JW, (2000) Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12: 83-93.
22. Tenzer S, Wee E, Burgevin A, Stewart-Jones G, Friis L, et al. (2009) Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol 10: 636-46.
23. Yewdell JW, (2006) Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25: 533-43.
24. Irvine K, Bennink J, (2006) Factors influencing immunodominance hierarchies in TCD8+-mediated antiviral responses. Expert Rev Clin Immunol 2: 135-47.
25. La Gruta NL, Kedzierska K, Pang K, Webby R, Davenport M, et al. (2006) A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc Natl Acad Sci USA 103: 994-9.
26. Kotturi MF, Scott I, Wolfe T, Peters B, Sidney J, et al. (2008) Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J Immunol 181: 2124-33.
27. Sacha JB, Reynolds MR, Buechler MB, Chung C, Jonas AK, et al. (2008) Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein. J Virol 82: 9293-8.
28. La Gruta NL, Rothwell WT, Cukalac T, Swan NG, Valkenburg SA, et al. (2010) Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J Clin Invest 120: 1885-94.
29. Chen W, McCluskey J, (2009) Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines. Adv Cancer Res 95: 203-47.
30. Jenkins MR, Webby R, Doherty PC, Turner SJ, (2009) Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting. J Immunol 177: 2917-25.
31. Willis RA, Kappler JW, Marrack PC, (2006) CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc Natl Acad Sci USA 103: 12063-8.
32. Newberg MH, McEvers KJ, Gorgone DA, Lifton MA, Baumeister SH, et al. (2006) Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol 176: 319-28.
33. Kastenmuller W, Gasteiger G, Gronau JH, Baier R, Ljapoci R, et al. (2007) Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J Exp Med 204: 2187-98.
34. Riedl P, Wieland A, Lamberth K, Buus S, Lemonnier F, et al. (2009) Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential. J Immunol 183: 370-80.
35. Vasconcelos JR, Hiyane MI, Marinho CR, Claser C, Machado AM, et al. (2004) Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. Hum Gene Ther 15: 878-86.
36. Machado AV, Cardoso JE, Claser C, Rodrigues MM, Gazzinelli RT, et al. (2006) Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase. Hum Gene Ther 17: 898-908.
37. de Alencar BC, Persechini PM, Haolla FA, de Oliveira G, Silverio JC, et al. (2009) Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination. Infect Immun 77: 4383-95.
38. Haolla FA, Claser C, de Alencar BC, Tzelepis F, de Vasconcelos JR, et al. (2009) Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. Vaccine 27: 5644-53.
39. Claser C, Espíndola NM, Sasso G, Vaz AJ, Boscardin SB, et al. (2007) Immunologically relevant strain polymorphism in the Amastigote Surface Protein 2 of Trypanosoma cruzi. Microbes Infect 9: 1011-9.
40. Oukka M, Manuguerra JC, Livaditis N, Tourdot S, Riche N, et al. (1996) Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J Immunol 157: 3039-45.
41. Friedrich TC, Valentine LE, Yant LJ, Rakasz EG, Piaskowski SM, et al. (2007) Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication. J Virol 81: 3465-76.
42. Holtappels R, Simon CO, Munks MW, Thomas D, Deegen P, et al. (2008) Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination. J Virol 82: 5781-96.
43. Ruckwardt TJ, Luongo C, Malloy AM, Liu J, Chen M, et al. (2010) Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope. J Immunol 185: 4673-80.
44. Araújo AF, de Alencar BC, Vasconcelos JR, Hiyane MI, Marinho CR, et al. (2005) CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2. Infect Immun 73: 6017-25.
45. Rodrigues M, Nussenzweig RS, Romero P, Zavala F, (1992) The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med 175: 895-905.
46. Li S, Rodrigues M, Rodriguez D, Rodriguez JR, Esteban M, et al. (1993) Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci USA 90: 5214-18.
47. Rodrigues M, Li S, Murata K, Rodriguez D, Rodriguez JR, et al. (1994) Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J Immunol 153: 4636-48.
48. Sedegah M, Jones TR, Kaur M, Hedstrom R, Hobart P, et al. (1998) Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc Natl Acad Sci USA 95: 7648-53.
49. Schneider J, Gilbert SC, Blanchard TJ, Hanke T, Robson KJ, et al. (1998) Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 4: 397-402.
50. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, et al. (2006) The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444: 937-40.
51. Mauduit M, Grüner AC, Tewari R, Depinay N, Kayibanda M, et al. (2009) A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites. PLoS One 4 (11): e7717.
52. Pavelic V, Matter MS, Mumprecht S, Breyer I, Ochsenbein AF, (2009) CTL induction by cross-priming is restricted to immunodominant epitopes. Eur J Immunol 39: 704-16.
53. Cazorla SI, Frank FM, Becker PD, Arnaiz M, Mirkin GA, et al. (2010) Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection. J Infect Dis 202: 136-44.
54. Blanchard N, Gonzalez F, Schaeffer M, Joncker NT, Cheng T, et al. (2008) Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat Immunol 9: 937-44.
55. Frickel EM, Sahoo N, Hopp J, Gubbels MJ, Craver MP, et al. (2008) Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. J Infect Dis 198: 1625-33.
56. Wilson DC, Grotenbreg GM, Liu K, Zhao Y, Frickel EM, et al. (2010) Differential regulation of effector- and central-memory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells. PLoS Pathog 6 (3): e1000815.
57. MacHugh ND, Connelley T, Graham SP, Pelle R, Formisano P, et al. (2009) CD8+ T-cell responses to Theileria parva are preferentially directed to a single dominant antigen: Implications for parasite strain-specific immunity. Eur J Immunol 39: 2459-69.